Siguazodan
Alternative Names: SKF 94836Latest Information Update: 05 Sep 1994
Price :
$50 *
At a glance
- Originator Unknown
- Developer GlaxoSmithKline
- Class Cardiotonics; Vasodilators
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure